Atsuko Kitano

848 citations
19 papers · 588 · 1 hit paper · h-index 8

Impact in

  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers
    • Cancer Treatment and Pharmacology
    • Cancer Cells and Metastasis
    • Peptidase Inhibition and Analysis
    • Monoclonal and Polyclonal Antibodies Research

Papers in

Atsuko Kitano

17 papers receiving 583 citations

Atsuko Kitano's Hit Papers

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study 2017 · 362 citations
3620+3+6Years since publication100200300

Peers

Atsuko Kitano
Comparison fields: 5 of 64
  • Oncology 465
  • Radiology, Nuclear Medicine and Imaging 204
  • Pulmonary and Respiratory Medicine 175
  • Cancer Research 68
  • Gastroenterology 14
Replace Christy Osgood with:
Christy Osgood United States
Eleonora Restuccia Switzerland
Minsig Choi United States
María Gión Spain
Praveen Sridhar United States
Elisa Fontana United Kingdom
Jeremy Wu Canada
Brent O’Carrigan United Kingdom
Amer Sami Canada
Atsuko Kitano relative to Christy Osgood United States Christy Osgood's profile →
Citations per field
00.5×3.4×
Christy Osgood · 1×
Citations per year

Countries citing papers authored by Atsuko Kitano

Since Specialization
Citations

This map shows the geographic impact of Atsuko Kitano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Kitano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Kitano more than expected).

Fields of papers citing papers by Atsuko Kitano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuko Kitano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Kitano. The network helps show where Atsuko Kitano may publish in the future.

Co-authors

The 25 scholars most cited alongside Atsuko Kitano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Atsuko Kitano Line = papers co-authored together Atsuko Kitano links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
Hit paper breakdown →
2017362
2 2017116
3 199930
4 199816
5 201513
6 201411
7 20199
8 20168
9 20234
10 20224
11 20174
12 20183
13 20143
14 20212
15 20151
16 20201
17 20241
18 20240
19 20240

About Atsuko Kitano

Atsuko Kitano is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Sociology and Political Science, Pulmonary and Respiratory Medicine and Genetics, having authored 19 papers that have together received 588 indexed citations. Recurring topics across this work include Family Support in Illness (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Cancer Risks and Factors (3 papers), HER2/EGFR in Cancer Research (2 papers), BRCA gene mutations in cancer (2 papers), Microfluidic and Capillary Electrophoresis Applications (2 papers), Bone health and treatments (2 papers) and Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (465 citations), Radiology, Nuclear Medicine and Imaging (204 citations), Pulmonary and Respiratory Medicine (175 citations), Cancer Research (68 citations) and Gastroenterology (14 citations). Atsuko Kitano has collaborated with scholars based in Japan, United States and Cameroon. Frequent co-authors include Chikako Shimizu, Yasuhiro Fujiwara, Kenji Tamura, Akihiko Shimomura, Kan Yonemori, Tatsunori Shimoi, Antoine Yver, Nobuaki Matsubara, Kohei Shitara and Yoichi Naito. Their work appears in journals such as Breast Cancer, ESMO Open, International Journal of Clinical Oncology, Electrophoresis and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact